Published by
@ShahidNShah
@ShahidNShah
February 23, 2023
Online
Better cell culture media, cell lines, and bioreactor strategies are responsible for yielding 10+g/l on a consistent basis. Going forward, companies will continue to implement new technologies and process designs to support emerging therapeutics. Our experts share their personal experiences and insight to help anticipate challenges and chose appropriate technologies to support your production strategies.
Read on cii.dryfta.com
Continue reading at evaluatingbiopharma.com
February 23 to February 24, 2023
San Francisco, United States
Connecting innovation decision makers to authoritative information, institutions, people and insights.
Medigy accurately delivers healthcare and technology information, news and insight from around the world.
Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.
© 2024 Netspective Foundation, Inc. All Rights Reserved.
Built on Dec 24, 2024 at 4:05am